Alnylam Pharmaceuticals' shares rose about 7% before the bell on Friday following U.S. approval for its drug for a rare and deadly heart disease, securing an entry into a market dominated by Pfizer's ...

Pfizer has officially kissed goodbye to its consumer health venture by selling its final 7.3% stake in Haleon for a tidy $3.3 ...

The White House is reportedly considering former U.S. Rep. Michael Burgess (R-Texas) as its nominee to head the CDC. Burgess, ...

The U.S. Department of Agriculture (USDA) on Thursday announced a $100M investment to combat the transmission of the bird flu virus in poultry, adding to the Trump administration's previously ...

If you're looking for reasonably priced stocks to pick up right now, you shouldn't overlook Pfizer (NYSE: PFE). The ...

Pfizer PFE has sold off its remaining stake in consumer health company Haleon HLN to institutional investors and Haleon ...

Amid rising risks, I favor high-yield stocks with strong business models. Check out the stock picks that offer stability, ...

Bristol Myers has dealt with patent cliffs the old-fashioned way -- by developing newer products that are now helping drive solid growth. That includes Reblozyl, a medicine for anemia in ...

Pfizer (NYSE:PFE – Get Free Report)‘s stock had its “buy” rating restated by research analysts at Guggenheim in a research ...

The stock market's performance in the coming year feels less certain than usual. Luckily, there's a well-established, ...

Pfizer (PFE) closed the most recent trading day at $26.21, moving -0.38% from the previous trading session. This move lagged the S&P 500's daily gain of 1.08%. Meanwhile, the Dow gained 0.92%, and the ...

We recently published a list of the 7 Most Undervalued Biotech Stocks To Invest In. In this article, we are going to take a ...